Media

Press Release: Sanofi-GSK next-generation COVID-19 booster delivers strong immune response against variants of concern, including Omicron

Press Release: Sanofi-GSK first to report a successful efficacy study against Omicron with COVID-19 Beta-containing vaccine

Plaquenil Summary of Product Characteristics

FDA to Conduct Priority Review of Cemiplimab as a Potential Treatment for Advanced Cutaneous Squamous Cell Carcinoma

EMA to review cemiplimab as a potential treatment for advanced cutaneous squamous cell carcinoma

EMA to review Dupixent® (dupilumab) as potential treatment for inadequately controlled moderate-to-severe asthma

EMA to review sotagliflozin as potential treatment for type 1 diabetes